|
|
|
 |
| |
| Carcinogenesis,
Teratogenesis & Mutagenesis
The forth Editorial Board
|
|
SHAN
Bao-en |
|
|
|
PERSONAL
DATA
Baoen Shan, Male, Birth date: May 24, 1962
EDUCATION BACKGROUND
Sep.1978-July1981, study in Hebei Medical College
Handan Branch. Sep.1984-July 1988, study in
Hebei medical University. April.1995-March 1999,
University of Occupational and Environmental
health, School of Medicine, Janpan. Major is
Tumor Immunology. Degree is Ph.D. & MD.
PROFESSIONAL EXPERIENCE
September 1981-December 1993. Research Assistant
and Lecturer in the Center Laboratory, the fourth
hospital of Hebei medical University. December
1993-March 1995. Visit research fellow in the
University of Occupational and Environmental
health, School of Medicine, Japan. April 1999-March
2000. Post Doctor Research in the University
of Occupational and Environmental Health, School
of Medicine, Japan. April 2000-Now. Abroad Mobile
Research Fellow in the University of Occupational
and Environmental Health, School of Medicine,
Japan. March 1999-Now. Professor and Chairman
in the Research center, the Fourth Hospital
of Hebei Medical University. August 2001-Now.
Chairman in the Laboratory of Hebei tumor gene
diagnosis, prevention ＆ tretment. October 2002-Now.
vice Chairman in the Cancer Research Institute
of Hebei Province.
PERSONAL DATA
The substance of major research: the study for
mechanism of chinese medical herb anti-tumors,
the carcinoma gene diagnosis, immuno-gene therapy
and biological therapy for cancer.
Society amphi-duty: the member of hebei province
decem-technology distinguishing youthes. Sub
secretary-general of Chinese society of immunology.
Sub-director and secretary-general of hebei
society of immunology. Sub-director commission
of hebei society of ecsomatics in chinese society
of medicine. Sub-director commission of special
anti-tumor committee in chinese society of mutagenic
agent. the editor of chinese journal of immunology、chinese
journal of carcinogenesis·tetatogenesis·mutagenesis、chinese
journal of practical tumor and chinese journal
of cancer precention and treatment.The commission
of chinese term authorization committee. |
|
| |
|
|
|
| |
 |
| |
 |
| Cheng
Shujun is currently as a professor of Cancer
Institute (Hospital), Chinese Academy of Medical Sciences
& Peking Union Medical College, Beijing, China,
and Chief Scientist of both China State Key Basic
Research Project “Fundamental investigation of human
carcinogenesis and cancer therapy and prevention”
and Beijing key Cancer Research Project “Tumor biomarker
profiling and human cancer diagnosis and therapy”.
He worked as a visiting scientist in Laboratoire de
Medicine Experimental, Institute de la Recherches
Scientifiques sur le Cancer, France (1978-1981), and
in Department of Pathology, Medical College of Ohio,
USA (1986-1987). He has established a series of short-term
tests for the detection of environmental carcinogens
and anti-carcinogens in China. He was elected as a
Member, Chinese Academy of Engineering in 1999. Dr.
Cheng is the President of Chinese Environmental Mutagen
Society, and Vice President of China Anticancer Association.
He found that the tea catechins showed a significant
inhibitory effect against human genital condylomas
and inflammatory hyperplasia. Based on the invention,
he and his collaborators had received international
patents “Composition for treating condyloma acuminate”
in 1998. This invention had been approved to go for
clinical phase III trial by US FDA. As invited speakers,
Dr. Cheng has visited many institutes at foreign countries
and attended at international conferences. |
|
| |
|
